Who owns REGENERON PHARMACEUTICALS, INC. (REGN)? Elite investor 13F holders

13 tracked elite investors reported holding REGENERON PHARMACEUTICALS, INC as of 2026-09-30, including Dodge & Cox Funds, Renaissance Technologies LLC, Southeastern Asset Management, Sound Shore, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

13 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Dodge & Cox FundsREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-13 00:00:003620351774.00 USD4774489.000000SharesreduceOriginal filing
Renaissance Technologies LLCREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-12 00:00:00206414743.00 USD272218.000000SharesaddOriginal filing
Southeastern Asset ManagementREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-16 00:00:00106282915.00 USD140165.000000SharesreduceOriginal filing
Sound ShoreREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-06 00:00:0095677750.00 USD126179.000000SharesreduceOriginal filing
Bridgewater AssociatesREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-16 00:00:0080326574.00 USD105934.000000SharesaddOriginal filing
Gotham Asset ManagementREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-16 00:00:0065999821.00 USD87040.000000SharesreduceOriginal filing
GMOREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-13 00:00:0053894799.00 USD71076.000000SharesreduceOriginal filing
D.E. ShawREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-16 00:00:0044461919.00 USD58636.000000SharesaddOriginal filing
Sarissa CapitalREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-16 00:00:003177151.00 USD4190.000000SharesholdOriginal filing
Maverick CapitalREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-16 00:00:001383084.00 USD1824.000000SharesbuyOriginal filing
GAMCOREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-12 00:00:00495150.00 USD653.000000SharesreduceOriginal filing
Pzena Investment ManagementREGENERON PHARMACEUTICALSSHARE2026-09-302026-10-30 00:00:00310132.00 USD409.000000SharesbuyOriginal filing
Ancora Advisors / Ancora HoldingsREGENERON PHARMACEUTICALSSHARE2026-09-302026-11-17 00:00:0057629.00 USD76.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown